Genetic engineering of T cells for the immunotherapy of haematological malignancies. | Tissue Antigens;79(1): 4-14, 2012 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Genetic engineering of T cells for the immunotherapy of haematological malignancies.

Casucci, M; Bondanza, A; Falcone, L; Provasi, E; Magnani, Z; Bonini, C.

Affiliation

Casucci M; Experimental Haematology Laboratory, PIBIC, Division of Regenerative Medicine, Stem Cell and Gene Therapy, S. Raffaele Scientific Institute, Milano, Italy.

Tissue Antigens ; 79(1): 4-14, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22150366

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Genetic Engineering / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Graft vs Leukemia Effect / Antigens, Neoplasm Limits: Animals / Humans Language: En Journal: Tissue Antigens Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Genetic Engineering / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Graft vs Leukemia Effect / Antigens, Neoplasm Limits: Animals / Humans Language: En Journal: Tissue Antigens Year: 2012 Document type: Article Affiliation country: Country of publication: